I am Mohammad Momin a Research Assistant Professor in the Department of Pharmaceutics at the School of Pharmacy in Virginia Commonwealth University, USA. I received my Ph.D. in Pharmacy from University of Otago in New Zealand (2018) with “Exceptional Doctoral Thesis” award and Master’s in Pharmaceutical Science from Jahangirnagar University, Bangladesh (2008). Before starting my PhD, I worked more than 5 years in Pharmaceutical Industries in both DPI and MDI product development.
My current research focuses on the development of high efficiency surfactant dry powder inhaler for both neonates and adults to treat respiratory distress syndrome using our excipient enhanced growth (EEG) formulation technology. Overall, my research focuses on the pulmonary and nasal formulation development, in vitro characterization of formulations and drug-device combination, etc. I published more than 45 peer-reviewed journal articles, more than 45 conference abstracts, 3 submitted patents and over 10 peer-reviewed conference papers. I have also served as a co-guest editor of a special issue of Respiratory drug delivery section in Frontiers in Drug Delivery journal. I have also been reviewing articles for most of the journals in our field including International Journal of Pharmaceutics (IJP), European Journal of Pharmaceutical Sciences (EJPS), Journal of Pharmaceutical Sciences (JPS) and AAPS PhramSciTech etc. I am a member of American Association of Pharmaceutical Scientists (AAPS).
I am Mohammad Momin a Research Assistant Professor in the Department of Pharmaceutics at the School of Pharmacy in Virginia Commonwealth University, USA. I received my Ph.D. in Pharmacy from University of Otago in New Zealand (2018) with “Exceptional Doctoral Thesis” award and Master’s in Pharmaceutical Science from Jahangirnagar University, Bangladesh (2008). Before starting my PhD, I worked more than 5 years in Pharmaceutical Industries in both DPI and MDI product development.
My current research focuses on the development of high efficiency surfactant dry powder inhaler for both neonates and adults to treat respiratory distress syndrome using our excipient enhanced growth (EEG) formulation technology. Overall, my research focuses on the pulmonary and nasal formulation development, in vitro characterization of formulations and drug-device combination, etc. I published more than 45 peer-reviewed journal articles, more than 45 conference abstracts, 3 submitted patents and over 10 peer-reviewed conference papers. I have also served as a co-guest editor of a special issue of Respiratory drug delivery section in Frontiers in Drug Delivery journal. I have also been reviewing articles for most of the journals in our field including International Journal of Pharmaceutics (IJP), European Journal of Pharmaceutical Sciences (EJPS), Journal of Pharmaceutical Sciences (JPS) and AAPS PhramSciTech etc. I am a member of American Association of Pharmaceutical Scientists (AAPS).